Living

US launches Section 301 probe into Germany over drug pricing

By Reuters Reuters
FILE PHOTO: U.S. Trade Representative Jamieson Greer speaks with reporters at the White House in Washington, D.C., U.S., April 2, 2026. REUTERS/Evan Vucci/File Photo
FILE PHOTO: U.S. Trade Representative Jamieson Greer speaks with reporters at the White House in Washington, D.C., U.S., April 2, 2026. REUTERS/Evan Vucci/File Photo Evan Vucci Reuters

WASHINGTON - The United States has initiated an investigation under Section 301 of the Trade Act of 1974 against Germany, U.S. Trade Representative Jamieson Greer said on Thursday.

The investigation will seek to determine whether persistent underpayment for innovative pharmaceutical products by Germany is unreasonable or discriminatory, the USTR said.

(Reporting by Jasper Ward in Washington; editing by Scott Malone)

Copyright Reuters or USA Today Network via Reuters Connect

This story was originally published June 18, 2026 at 8:25 PM.

Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER